The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
- Eric Simões
Access Resources
About
This article discusses the significant burden of respiratory syncytial virus (RSV) in infants in the United States. It covers the epidemiology, hospitalization rates, mortality, costs, and impact on healthcare systems and families. The article highlights the development of preventive strategies like long-acting monoclonal antibodies and maternal immunization to combat RSV. It also addresses the challenges in testing and diagnosing RSV, the economic costs associated with RSV hospitalizations, and the disparities in burden and mortality rates among different socioeconomic groups.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.